Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecadenoson Alone and in Combination with Esmolol in Rapid Atrial Fibrillation
NCT00713401Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2008
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tecadenoson in Atrial fibrillation (AFib), sponsored by Gilead Sciences. Started Feb 2008; status: completed.
02
Drugs
tecadenoson
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00713401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713401.